Literature DB >> 25934787

Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?

Zhihong Qiao1, Ningyang Jia2, Qian He3.   

Abstract

This paper aimed to evaluate the effect of preoperative transarterial embolization (TAE) on estimated blood loss (EBL) during surgical excision of the vertebral tumors. Three hundred and forty-eight patients with spinal tumors were retrospectively analyzed. The preoperative TAE group consisted of 190 patients and the control group consisted of 158 patients. Gelatin sponge particles mixed withy contrast agent were used in the TAE group to embolize the tumor-feeding artery. The factors evaluated included: the time interval between embolism and surgery; the number of vertebrae involved by the tumor; pathological type of tumor; surgical approach; extent of excision and instrumental fixation. The time interval (P = 0.4669)between embolism and surgery had no significant correlation with EBL during surgery. The pathological diagnosis of vertebral tumor such as plasma cell myeloma, giant cell tumor, chondrosarcoma, hemangioma and metastasis had no significant correlation with EBL between the TAE group and control group during surgery, while the EBL of chordoma in the TAE group was significantly higher than that in the control group (p = 0.0254). The number of vertebrae involved (p = 0.4669, 0.6804, 0.6677), posterior approach (p = 0.3015), anterior approach (p = 0.2446), partial excision (p = 0.1911) and instrumental fixation (p = 0.1789) had no significant correlation with EBL during surgery between the TAE group and the control group. This study showed that preoperative TAE of the spinal tumor had no significant effect on intra-operative blood loss during surgical excision of the spinal tumor. In view of the risk of embolism, this method should be carefully considered.
© The Author(s) 2015 Reprints and permissions:]br]sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Spine; embolism; estimated blood loss; tumor

Mesh:

Year:  2015        PMID: 25934787      PMCID: PMC4757205          DOI: 10.15274/inr-2014-10091

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  20 in total

1.  Vascular metastatic lesions of the spine: preoperative embolization.

Authors:  F E Gellad; N Sadato; Y Numaguchi; A M Levine
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

2.  Preoperative embolization in the treatment of osseous metastases from renal cell carcinoma.

Authors:  M W Roscoe; R J McBroom; E St Louis; H Grossman; R Perrin
Journal:  Clin Orthop Relat Res       Date:  1989-01       Impact factor: 4.176

3.  Transfemoral selective embolisation in the treatment of some cranial and vertebro-spinal vascular malformations and tumours. Preliminary results.

Authors:  A Benati; G Dalle Ore; R Da Pian; A Bricolo; A Maschio; S Perini
Journal:  J Neurosurg Sci       Date:  1974 Oct-Dec       Impact factor: 2.279

4.  Embolization of spinal tumors: vascular anatomy, indications, and technique.

Authors:  Efe Ozkan; Sanjay Gupta
Journal:  Tech Vasc Interv Radiol       Date:  2011-09

5.  Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss.

Authors:  C Manke; T Bretschneider; M Lenhart; M Strotzer; C Neumann; J Gmeinwieser; S Feuerbach
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

6.  Pre-operative embolisation of metastatic paraganglioma of the thoracic spine.

Authors:  R B Kwan; A M Erasmus; A W Hunn; A Dubey; P Waites; P J Jessup; J R Burgess; A Beasley
Journal:  J Clin Neurosci       Date:  2010-01-13       Impact factor: 1.961

7.  Retrospective analysis of preoperative embolization of spinal tumors.

Authors:  M A Wilson; D L Cooke; B Ghodke; S K Mirza
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

8.  Preoperative transarterial embolization of spinal column neoplasms.

Authors:  T P Smith; L Gray; J N Weinstein; W J Richardson; C S Payne
Journal:  J Vasc Interv Radiol       Date:  1995 Nov-Dec       Impact factor: 3.464

9.  Preoperative transarterial embolization of vertebral metastases.

Authors:  Raphael Guzman; Susan Dubach-Schwizer; Paul Heini; Karl-Olof Lovblad; Daniel Kalbermatten; Gerhard Schroth; Luca Remonda
Journal:  Eur Spine J       Date:  2004-09-16       Impact factor: 3.134

10.  Results of preoperative embolization for metastatic spinal neoplasms.

Authors:  Vikram C Prabhu; Mark H Bilsky; Kedar Jambhekar; Katherine S Panageas; Patrick J Boland; Eric Lis; Linda Heier; P Kim Nelson
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

View more
  5 in total

1.  Assessing Vascularity of Osseous Spinal Metastases with Dual-Energy CT-DSA: A Pilot Study Compared with Catheter Angiography.

Authors:  Y-C Huang; F-Y Tsuang; C-W Lee; C-Y Wu; Y-H Lin
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-04       Impact factor: 3.825

2.  Surgical treatment of compressive spinal hemangioma : A case series of three patients and literature review.

Authors:  Yun-Lin Chen; Xu-Dong Hu; Nan-Jian Xu; Wei-Yu Jiang; Wei-Hu Ma
Journal:  Orthopade       Date:  2018-03       Impact factor: 1.087

3.  Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.

Authors:  Ning Lang; Yang Zhang; Enlong Zhang; Jiahui Zhang; Daniel Chow; Peter Chang; Hon J Yu; Huishu Yuan; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2019-02-28       Impact factor: 2.546

4.  Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization.

Authors:  Yuto Maeda; Yuji Miyamoto; Yukiharu Hiyoshi; Kojiro Eto; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Int Cancer Conf J       Date:  2022-08-01

5.  Preoperative embolization in patients with metastatic spinal cord compression: mandatory or optional?

Authors:  Chul Gie Hong; Jae Hwan Cho; Dae Chul Suh; Chang Ju Hwang; Dong-Ho Lee; Choon Sung Lee
Journal:  World J Surg Oncol       Date:  2017-02-14       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.